PremiumCompany AnnouncementsCleo Diagnostics Advances Ovarian Cancer Test Development Cleo Diagnostics Reports Reduced Losses and Advances Clinical Trials Cleo Diagnostics Clarifies Unique Market Focus and Advances in Ovarian Cancer Detection PremiumCompany AnnouncementsCleo Diagnostics Expands Ovarian Cancer Trial with Key Collaborations Cleo Diagnostics Advances in U.S. Ovarian Cancer Trials Cleo Diagnostics Schedules AGM, Shareholders to Vote PremiumCompany AnnouncementsCLEO Diagnostics Advances Ovarian Cancer Test Cleo Diagnostics Advances FDA Approval Process CLEO Diagnostics Seeks ASX Quotation for Shares